Mar 22 | Mar 21 | Mar 20 | Mar 19 | Mar 18 | |
---|---|---|---|---|---|
Income Statement | - | ||||
Total Revenue | - | - | - | - | - |
Gross Profit | - | - | - | - | - |
EBIT | - | - | - | - | - |
EBITDA | - | - | - | - | - |
Net Income Common Stockholders | - | - | - | - | - |
Balance Sheet | - | ||||
Cash, Cash Equivalents and Short-Term Investments | $ 202.26M | $ 139.56M | $ 116.14M | $ 115.18M | $ 80.52M |
Total Assets | $ 3.03B | $ 2.49B | $ 2.30B | $ 1.50B | $ 1.38B |
Total Debt | $ 814.56M | $ 827.20M | $ 900.38M | $ 245.66M | $ 277.37M |
Net Debt | $ 612.30M | $ 687.64M | $ 784.24M | $ 130.48M | $ 196.85M |
Total Liabilities | $ 1.60B | $ 1.37B | $ 1.34B | $ 664.57M | $ 664.00M |
Stockholders Equity | $ 1.43B | $ 1.12B | $ 966.34M | $ 838.32M | $ 712.40M |
Cash Flow | - | ||||
Free Cash Flow | - | - | - | - | - |
Operating Cash Flow | - | - | - | - | - |
Investing Cash Flow | - | - | - | - | - |
Financing Cash Flow | - | - | - | - | - |